Orgenesis Inc.
ORGS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -98.5% | 1.5% | 364% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -1,080.2% | 43.3% | 20.7% | -306.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11,456.2% | -22.6% | -44.3% | -1,231.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10,445.5% | -41.3% | -50.9% | -1,252.1% |
| EPS Diluted | -1.91 | -0.59 | -0.74 | -4.46 |
| % Growth | -223.7% | 20.3% | 83.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |